{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:42:33Z","timestamp":1786164153746,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,7]]},"DOI":"10.7759\/cureus.114148","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:54:12Z","timestamp":1786161252000},"source":"Crossref","is-referenced-by-count":0,"title":["Trends in Septicemia- and Influenza\/Pneumonia-Related Mortality Among Patients With Malignant Neoplasms: A Nationwide Population-Based Study"],"prefix":"10.7759","author":[{"given":"Pankti K","family":"Raval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigarkumar S","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidhubhusan","family":"Raul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathusha","family":"Harikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishva","family":"Rajpuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rithik","family":"Dharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70090","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung H","year":"2026","unstructured":"Sung H, Filho AM, Laversanne M, et al.. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA Cancer J Clin. 2026, 76:e70090. 10.3322\/caac.70090","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel RL","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024, 74:12-49. 10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-04220-6_2","article-title":"Epidemiology of infections in cancer patients","author":"Zembower TR","year":"2014","unstructured":"Zembower TR. Epidemiology of infections in cancer patients. Cancer Treat Res. 2014. 161:43-89. 10.1007\/978-3-319-04220-6_2"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05073-0","article-title":"Septic shock in the immunocompromised cancer patient: a narrative review","volume":"28","author":"Nates JL","year":"2024","unstructured":"Nates JL, P\u00e8ne F, Darmon M, et al.. Septic shock in the immunocompromised cancer patient: a narrative review. Crit Care. 2024, 28:285. 10.1186\/s13054-024-05073-0","journal-title":"Crit Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000156","article-title":"Pneumonia in the neutropenic cancer patient","volume":"21","author":"Evans SE","year":"2015","unstructured":"Evans SE, Ost DE. Pneumonia in the neutropenic cancer patient. Curr Opin Pulm Med. 2015, 21:260-71. 10.1097\/MCP.0000000000000156","journal-title":"Curr Opin Pulm Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-021-00433-7","article-title":"Fatal infections among cancer patients: a population-based study in the United States","volume":"10","author":"Zheng Y","year":"2021","unstructured":"Zheng Y, Chen Y, Yu K, et al.. Fatal infections among cancer patients: a population-based study in the United States. Infect Dis Ther. 2021, 10:871-95. 10.1007\/s40121-021-00433-7","journal-title":"Infect Dis Ther"},{"key":"ref7","unstructured":"CDC WONDER. Multiple cause of death, 1999-2020. (2023). https.\/\/wonder.cdc.gov\/mcd-icd10.html."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans L","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al.. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021, 47:1181-247. 10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1647944","article-title":"Infectious adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis based on FAERS database","volume":"16","author":"Song S","year":"2025","unstructured":"Song S, Yang Y, Hu Q, et al.. Infectious adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis based on FAERS database. Front Immunol. 2025, 16:1647944. 10.3389\/fimmu.2025.1647944","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin LG","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, et al.. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014, 58:e44-100. 10.1093\/cid\/cit684","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.7571","article-title":"Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals","volume":"2","author":"Rhee C","year":"2019","unstructured":"Rhee C, Jones TM, Hamad Y, et al.. Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals. JAMA Netw Open. 2019, 2:e187571. 10.1001\/jamanetworkopen.2018.7571","journal-title":"JAMA Netw Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy378","article-title":"Difficult-to-treat resistance in Gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents","volume":"67","author":"Kadri SS","year":"2018","unstructured":"Kadri SS, Adjemian J, Lai YL, et al.. Difficult-to-treat resistance in Gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents. Clin Infect Dis. 2018, 67:1803-14. 10.1093\/cid\/ciy378","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8648-x","article-title":"Sexual dimorphism in innate immunity","volume":"56","author":"Jaillon S","year":"2019","unstructured":"Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol. 2019, 56:308-21. 10.1007\/s12016-017-8648-x","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2012.00268","article-title":"Gender differences in cancer susceptibility: an inadequately addressed issue","volume":"3","author":"Dorak MT","year":"2012","unstructured":"Dorak MT, Karpuzoglu E. Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet. 2012, 3:268. 10.3389\/fgene.2012.00268","journal-title":"Front Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2018.04.013","article-title":"Racial disparities in guideline-concordant cancer care and mortality in the United States","volume":"3","author":"Fang P","year":"2018","unstructured":"Fang P, He W, Gomez D, et al.. Racial disparities in guideline-concordant cancer care and mortality in the United States. Adv Radiat Oncol. 2018, 3:221-9. 10.1016\/j.adro.2018.04.013","journal-title":"Adv Radiat Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21812","article-title":"American Cancer Society's report on the status of cancer disparities in the United States, 2023","volume":"74","author":"Islami F","year":"2024","unstructured":"Islami F, Baeker Bispo J, Lee H, et al.. American Cancer Society's report on the status of cancer disparities in the United States, 2023. CA Cancer J Clin. 2024, 74:124-55. 10.3322\/caac.21812","journal-title":"CA Cancer J Clin"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6614a1","article-title":"Invasive cancer incidence, 2004-2013, and deaths, 2006-2015, in nonmetropolitan and metropolitan counties\u2014United States","volume":"66","author":"Henley SJ","year":"2017","unstructured":"Henley SJ, Anderson RN, Thomas CC, Massetti GM, Peaker B, Richardson LC. Invasive cancer incidence, 2004-2013, and deaths, 2006-2015, in nonmetropolitan and metropolitan counties\u2014United States. MMWR Surveill Summ. 2017, 66:1-13. 10.15585\/mmwr.ss6614a1","journal-title":"MMWR Surveill Summ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-17-0430","article-title":"Rural-urban differences in cancer incidence and trends in the United States","volume":"27","author":"Zahnd WE","year":"2018","unstructured":"Zahnd WE, James AS, Jenkins WD, et al.. Rural-urban differences in cancer incidence and trends in the United States. Cancer Epidemiol Biomarkers Prev. 2018, 27:1265-74. 10.1158\/1055-9965.EPI-17-0430","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00032","article-title":"Vaccination of adults with cancer: ASCO guideline","volume":"42","author":"Kamboj M","year":"2024","unstructured":"Kamboj M, Bohlke K, Baptiste DM, et al.. Vaccination of adults with cancer: ASCO guideline. J Clin Oncol. 2024, 42:1699-721. 10.1200\/JCO.24.00032","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/519988-trends-in-septicemia--and-influenzapneumonia-related-mortality-among-patients-with-malignant-neoplasms-a-nationwide-population-based-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:54:18Z","timestamp":1786161258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/519988-trends-in-septicemia--and-influenzapneumonia-related-mortality-among-patients-with-malignant-neoplasms-a-nationwide-population-based-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.114148","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}